What is the most recent earnings date for 1ABT stock?
ABBOTT LABORATORIES (1ABT.MI) last reported earnings on 1/22/2026.
BIT:1ABT • US0028241000
Past quarterly earnings results for ABBOTT LABORATORIES (1ABT.MI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1.50 | 1.51 | -0.75% | 11.94% | 11.459B | 11.921B | -3.88% | 4.42% |
| Q3 2025 | 1.30 | 1.31 | -1.06% | 7.44% | 11.369B | 11.518B | -1.29% | 6.90% |
| Q2 2025 | 1.26 | 1.27 | -0.58% | 10.53% | 11.142B | 11.179B | -0.33% | 7.37% |
| Q1 2025 | 1.09 | 1.08 | 0.73% | 11.22% | 10.358B | 10.502B | -1.37% | 3.95% |
| Q4 2024 | 1.34 | 1.36 | -1.16% | 12.61% | 10.974B | 11.122B | -1.33% | 7.16% |
| Q3 2024 | 1.21 | 1.21 | -0.34% | 6.14% | 10.635B | 10.655B | -0.19% | 4.85% |
| Q2 2024 | 1.14 | 1.12 | 2.22% | 5.56% | 10.377B | 10.474B | -0.93% | 4.00% |
| Q1 2024 | 0.98 | 0.96 | 1.61% | -4.85% | 9.964B | 9.979B | -0.15% | 2.23% |
| Q4 2023 | 1.19 | 1.20 | -0.89% | 15.53% | 10.241B | 10.282B | -0.40% | 1.49% |
| Q3 2023 | 1.14 | 1.11 | 2.82% | -0.87% | 10.143B | 9.904B | 2.41% | -2.56% |
| Q2 2023 | 1.08 | 1.06 | 1.87% | -24.48% | 9.978B | 9.795B | 1.87% | -11.36% |
| Q1 2023 | 1.03 | 1.00 | 3.24% | -40.46% | 9.747B | 9.733B | 0.14% | -18.06% |
| Q4 2022 | 1.03 | 0.93 | 11.12% | -21.97% | 10.091B | 9.762B | 3.37% | -12.01% |
| Q3 2022 | 1.15 | 0.95 | 20.60% | -17.86% | 10.41B | 9.777B | 6.47% | -4.74% |
| Q2 2022 | 1.43 | 1.14 | 25.59% | 22.22% | 11.257B | 10.422B | 8.01% | 10.11% |
| Q1 2022 | 1.73 | 1.48 | 16.92% | 31.06% | 11.895B | 11.097B | 7.19% | 13.76% |
| Q4 2021 | 1.32 | 1.22 | 8.36% | -8.97% | 11.468B | 10.815B | 6.04% | 7.17% |
| Q3 2021 | 1.40 | 0.95 | 46.65% | 42.86% | 10.928B | 9.655B | 13.18% | 23.44% |
| Q2 2021 | 1.17 | 1.03 | 13.83% | 105.26% | 10.223B | 9.787B | 4.45% | 39.51% |
| Q1 2021 | 1.32 | 1.29 | 2.59% | 103.08% | 10.456B | 10.793B | -3.12% | 35.34% |
| Q4 2020 | 1.45 | 1.37 | 6.14% | - | 10.701B | 10.035B | 6.64% | - |
| Q3 2020 | 0.98 | 0.92 | 6.89% | - | 8.853B | 8.624B | 2.66% | - |
| Q2 2020 | 0.57 | 0.43 | 33.23% | - | 7.328B | 6.875B | 6.59% | - |
| Q1 2020 | 0.65 | 0.59 | 10.56% | - | 7.726B | 7.415B | 4.19% | - |
Notes
ABBOTT LABORATORIES (1ABT.MI) last reported earnings on 1/22/2026.
ABBOTT LABORATORIES (1ABT.MI) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, ABBOTT LABORATORIES (1ABT.MI) has beaten EPS estimates in 1 out of 4 releases.